- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 493
ASG acquires Homebot
Mortgage advice provider Homebot has been bought by ASG three years after raising seed funding from investors including Black Knight Financial Services and Axel Springer.
Jun 26, 2020Element enlists corporates in $18m series B
Industrial data repository Element has now received $40m in total, Evonik, Schneider Electric Ventures, Honeywell and ABB having backed its latest round.
Jun 26, 2020Lennar books room in Sonder's $170m series E
The short-term apartment provider raised the funding at a $1.3bn valuation and is seeking another $30m to close the round at $200m.
Jun 26, 2020W3BCloud wheels out convertible debt financing
AMD and ConsenSys formed the decentralised data centre developer as a joint venture and have both contributed to a $20.5m round.
Jun 26, 2020iTeos eyes $100m initial public offering
The 6 Dimensions Capital-backed cancer immunotherapy developer has raised more than $200m in funding and has filed to raise up to $100m.
Jun 26, 2020CMG sees its way to $25m
Capital Markets Gateway added the funding from investors including Shea Ventures, Barclays, Citi, Goldman Sachs, JP Morgan, Morgan Stanley and Fidelity.
Jun 26, 2020NSF picks Panchanathan as director
Sethuraman Panchanathan has been appointed the new director of the US National Science Foundation, having previously held executive positions at ASU.
Jun 26, 2020Charles Schwab moves to Motif acquisition
Renren has exited the thematic stock investing platform in an acquisition of undisclosed size by Charles Schwab that followed $126m in funding.
Jun 25, 2020Pionyr maps out $1.47bn Gilead deal
Gilead Sciences will invest $275m in return for a 49.9% stake as part of a deal that could see it purchase the cancer immunotherapy developer outright.
Jun 25, 2020GV helps Sana secure $700m
Sana Biotechnology has closed its first round at more than $700m after investors including GV swung behind its vision to commercialise cell therapies.
Jun 25, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


